Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine vs vitamin C vs saline for discomfort after Lugol's iodine esophageal staining
ChiCTR2300070042Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Shihezi University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acetylcysteine and ascorbic acid in esophageal cancer and Esophageal Squamous Cell Carcinoma (ESCC) (3 arms), sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoint: Visual analogue scale discomfort score. Started Apr 2023; status: recruiting.
02
Drugs
acetylcysteineascorbic acid
03
Conditions
esophageal cancerEsophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ChiCTR2300070042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070042.